INR 500.05
(-0.28%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 2.45 Billion INR | 39.72% |
2022 | 1.75 Billion INR | 28.93% |
2021 | 1.36 Billion INR | -14.4% |
2020 | 1.59 Billion INR | -12.14% |
2019 | 1.81 Billion INR | 1.6% |
2018 | 1.78 Billion INR | -12.53% |
2017 | 2.03 Billion INR | -21.82% |
2016 | 2.6 Billion INR | -0.94% |
2015 | 2.63 Billion INR | -0.34% |
2014 | 2.64 Billion INR | 0.95% |
2013 | 2.61 Billion INR | -2.04% |
2012 | 2.67 Billion INR | 10.05% |
2011 | 2.42 Billion INR | 16.28% |
2010 | 2.08 Billion INR | 26.9% |
2009 | 1.64 Billion INR | 1.89% |
2008 | 1.61 Billion INR | 2.68% |
2007 | 1.57 Billion INR | -3.54% |
2006 | 1.63 Billion INR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | -4.77 Billion INR | -294.62% |
2024 Q2 | 2.81 Billion INR | 159.0% |
2023 Q4 | 2.45 Billion INR | 0.0% |
2023 FY | 2.45 Billion INR | 39.72% |
2023 Q1 | - INR | -100.0% |
2023 Q2 | 2.52 Billion INR | 0.0% |
2023 Q3 | - INR | -100.0% |
2022 Q1 | - INR | -100.0% |
2022 FY | 1.75 Billion INR | 28.93% |
2022 Q3 | - INR | -100.0% |
2022 Q2 | 2.36 Billion INR | 0.0% |
2022 Q4 | 1.75 Billion INR | 0.0% |
2021 Q2 | 1.92 Billion INR | 0.0% |
2021 Q1 | - INR | -100.0% |
2021 FY | 1.36 Billion INR | -14.4% |
2021 Q4 | 1.36 Billion INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2020 Q3 | - INR | -100.0% |
2020 Q2 | 1.91 Billion INR | 0.0% |
2020 FY | 1.59 Billion INR | -12.14% |
2020 Q4 | 1.59 Billion INR | 0.0% |
2019 Q2 | 1.93 Billion INR | 0.0% |
2019 Q4 | 1.81 Billion INR | 0.0% |
2019 Q1 | - INR | -100.0% |
2019 FY | 1.81 Billion INR | 1.6% |
2018 Q1 | - INR | -100.0% |
2018 FY | 1.78 Billion INR | -12.53% |
2018 Q4 | 1.78 Billion INR | 0.0% |
2018 Q3 | - INR | -100.0% |
2018 Q2 | 2.15 Billion INR | 0.0% |
2017 FY | 2.03 Billion INR | -21.82% |
2017 Q1 | - INR | -100.0% |
2017 Q2 | 2.74 Billion INR | 0.0% |
2017 Q3 | - INR | -100.0% |
2017 Q4 | 2.03 Billion INR | 0.0% |
2016 FY | 2.6 Billion INR | -0.94% |
2016 Q2 | 2.6 Billion INR | 0.0% |
2016 Q1 | - INR | -100.0% |
2016 Q3 | - INR | -100.0% |
2016 Q4 | 2.6 Billion INR | 0.0% |
2015 Q3 | - INR | -100.0% |
2015 Q2 | 2.69 Billion INR | 0.0% |
2015 FY | 2.63 Billion INR | -0.34% |
2015 Q1 | - INR | -100.0% |
2015 Q4 | 2.63 Billion INR | 0.0% |
2014 Q3 | - INR | -100.0% |
2014 FY | 2.64 Billion INR | 0.95% |
2014 Q4 | 2.64 Billion INR | 0.0% |
2014 Q2 | 2.61 Billion INR | 0.0% |
2014 Q1 | - INR | -100.0% |
2013 Q1 | - INR | -100.0% |
2013 FY | 2.61 Billion INR | -2.04% |
2013 Q4 | 2.61 Billion INR | 0.0% |
2013 Q3 | - INR | -100.0% |
2013 Q2 | 2.62 Billion INR | 0.0% |
2012 Q3 | - INR | -100.0% |
2012 Q2 | 5.13 Billion INR | 0.0% |
2012 FY | 2.67 Billion INR | 10.05% |
2012 Q4 | 2.67 Billion INR | 0.0% |
2011 FY | 2.42 Billion INR | 16.28% |
2010 FY | 2.08 Billion INR | 26.9% |
2009 FY | 1.64 Billion INR | 1.89% |
2008 FY | 1.61 Billion INR | 2.68% |
2007 FY | 1.57 Billion INR | -3.54% |
2006 FY | 1.63 Billion INR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Apollo Hospitals Enterprise Limited | 94.32 Billion INR | 97.398% |
Artemis Medicare Services Limited | 5.16 Billion INR | 52.503% |
Aster DM Healthcare Limited | 129.61 Billion INR | 98.106% |
Fortis Healthcare Limited | 47.32 Billion INR | 94.813% |
HealthCare Global Enterprises Limited | 18.42 Billion INR | 86.676% |
Krishna Institute of Medical Sciences Limited | 17.58 Billion INR | 86.043% |
Lotus Eye Hospital and Institute Limited | 72.17 Million INR | -3301.178% |
Max Healthcare Institute Limited | 35.91 Billion INR | 93.166% |
Max India Limited | 1.92 Billion INR | -27.854% |
Global Health Limited | 13.98 Billion INR | 82.447% |
Narayana Hrudayalaya Limited | 27.39 Billion INR | 91.039% |
Rainbow Children's Medicare Limited | 9.05 Billion INR | 72.889% |
Shalby Limited | 5.99 Billion INR | 59.069% |